Showing results (171-180 of 363) with videos related to

Sort By:
Pageof 37
Breast Cancer Research and Treatment|April 23, 2021
Prognostic value of the 21-gene recurrence score for regional recurrence in patients with estrogen receptor-positive breast cancerMinji Koh, Jinhong Jung, Su Ssan Kim, et al.
In Vivo (Athens, Greece)|April 29, 2021
Undervaluation of Radiotherapy for Gross Desmoid Tumors: The Need for Absolute Volume AssessmentYeon Joo Kim, Si Yeol Song, Wanlim Kim, et al.
Radiation Oncology Journal|October 18, 2017
Role of fractionated radiotherapy in patients with hemangioma of the cavernous sinusSunmin Park, Sang Min Yoon, Sumin Lee, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|November 7, 2014
Association between socioeconomic status and altered appearance distress, body image, and quality of life among breast cancer patientsOliver Chang, Eun-Kyung Choi, Im-Ryung Kim, et al.
Scientific Data|December 12, 2023
Chromosome-level genome assembly and annotation of the Antarctica whitefin plunderfish Pogonophryne albipinnaEuna Jo, Soyun Choi, Seung Jae Lee, et al.
Menopause (New York, N.Y.)|March 19, 2015
Prevalence and severity of menopause symptoms and associated factors across menopause status in Korean womenGyeyoon Yim, Younjhin Ahn, Yoosoo Chang, et al.
International Journal of Nanomedicine|July 24, 2015
Virosomes of hepatitis B virus envelope L proteins containing doxorubicin: synergistic enhancement of human liver-specific antitumor growth activity by radiotherapyQiushi Liu, Joohee Jung, Masaharu Somiya, et al.
Radiation Oncology (London, England)|November 22, 2015
Clinical efficacy of stereotactic ablative radiotherapy for lung metastases arising from colorectal cancerJinhong Jung, Si Yeol Song, Jong Hoon Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|November 28, 2012
Clinical prognostic factors and grading system for rib fracture following stereotactic body radiation therapy (SBRT) in patients with peripheral lung tumorsSu Ssan Kim, Si Yeol Song, Jungwon Kwak, et al.
Investigational New Drugs|November 8, 2017
Combination treatment with docetaxel and histone deacetylase inhibitors downregulates androgen receptor signaling in castration-resistant prostate cancerSang Eun Park, Ha-Gyeong Kim, Dong Eun Kim, et al.
Pageof 37